INGREZZA Trademark

Trademark Overview

On Friday, November 11, 2022, a trademark application was filed for INGREZZA with the United States Patent and Trademark Office. The USPTO has given the INGREZZA trademark a serial number of 97978251. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, September 12, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The INGREZZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for movement disorders, namely, chorea associated with Huntington's Disease
ingrezza

General Information

Serial Number97978251
Word MarkINGREZZA
Filing DateFriday, November 11, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements

Description of MarkThe mark consists of a sequence of right pointing arrows and the word "INGREZZA".
Goods and ServicesPharmaceutical preparations for human use for movement disorders, namely, chorea associated with Huntington's Disease
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 3, 2022
Primary Code005
First Use Anywhere DateThursday, February 1, 2024
First Use In Commerce DateThursday, February 1, 2024

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Saturday, December 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 15, 2022NEW APPLICATION ENTERED
Tuesday, December 6, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 25, 2023ASSIGNED TO EXAMINER
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, April 12, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, April 12, 2024TEAS STATEMENT OF USE RECEIVED
Friday, April 12, 2024DIVISIONAL REQUEST RECEIVED
Friday, April 12, 2024USE AMENDMENT FILED
Tuesday, April 23, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 10, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 10, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, September 12, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 12, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

ingrezza chorea associated huntington disease namely disorders preparations human movement pharmaceutical